IDEX Corp (IEX) SVP Lisa Anderson exercises 385 options and sells matching shares
Rhea-AI Filing Summary
IDEX Corp senior executive Lisa M. Anderson, SVP, GC, CAO & Corporate Secretary, exercised options to acquire 385 shares of common stock at an exercise price of $93.27 per share, originally granted with an exercise date of February 22, 2018 and expiring February 22, 2027. On the same day, she sold 385 shares of common stock at a weighted average price of $238.5949 per share, with individual trade prices ranging from $238.39 to $238.73. Following the transaction, the reported option position of 385 options was reduced to 0.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 385 shares ($56K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Anderson Lisa M
Role
SVP, GC, CAO & Corp Sec
Sold
385 shs ($92K)
Approx. gross sale proceeds
$92K
Approx. exercise cost
$36K
Approx. pre-tax spread
$56K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | OPTIONS (RIGHT TO BUY) | 385 | $0.00 | $0.00 |
| Exercise | COMMON STOCK | 385 | $93.27 | $36K |
| Sale | COMMON STOCK F1 | 385 | $238.5949 | $92K |
Holdings After Transaction:
OPTIONS (RIGHT TO BUY) — 0 shares (Direct);
COMMON STOCK — 4,327 shares (Direct)
Footnotes (1)
- F1. The transaction was executed in multiple trades at prices ranging from $238.39 to $238.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 1 of this Form 4.
Key Figures
Shares exercised: 385 shares
Option exercise price: $93.27 per share
Weighted average sale price: $238.5949 per share
+3 more
6 metrics
Shares exercised
385 shares
Options exercised into common stock on August 12, 2026
Option exercise price
$93.27 per share
Exercise price of options granted on February 22, 2018
Weighted average sale price
$238.5949 per share
Common stock sold on August 12, 2026
Sale price range
$238.39–$238.73 per share
Price range of multiple trades in the reported sale
Options after transaction
0 options
Options (Right to Buy) position following the 385-share exercise
Option expiration date
February 22, 2027
Expiration of the exercised options grant
Key Terms
Options (Right to Buy), derivative security, weighted average sale price, multiple trades
4 terms
Options (Right to Buy) financial
"security_title: "OPTIONS (RIGHT TO BUY)""
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average sale price financial
"The price reported in Column 4 above reflects the weighted average sale price."
multiple trades financial
"The transaction was executed in multiple trades at prices ranging"
FAQ
What did IDEX (IEX) executive Lisa M. Anderson report in this Form 4?
Lisa M. Anderson reported exercising options for 385 IDEX shares at $93.27 each and selling 385 common shares on August 12, 2026 at a weighted average price of $238.5949 per share.
What options did the IDEX (IEX) executive exercise in this transaction?
The executive exercised 385 options to buy IDEX common stock at an exercise price of $93.27 per share. These options had an exercise date of February 22, 2018 and an expiration date of February 22, 2027.
What position does the reporting person hold at IDEX (IEX)?
The reporting person, Lisa M. Anderson, serves as Senior Vice President, General Counsel, Chief Administrative Officer and Corporate Secretary of IDEX, indicating a key executive and legal leadership role at the company.
Were the IDEX (IEX) option holdings affected by this transaction?
Yes. The filing shows the options position of 385 options used in this transaction was reduced to 0 following the exercise, meaning this specific option grant no longer remains outstanding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
